Cargando…
Mortality and the Use of Antithrombotic Therapies Among Nursing Home Residents with COVID‐19
BACKGROUND/OBJECTIVES: Nursing home (NH) residents are a vulnerable population, susceptible to respiratory disease outbreaks such as coronavirus disease 2019 (COVID‐19). Poor outcome in COVID‐19 is at least partly attributed to hypercoagulability, resulting in a high incidence of thromboembolic comp...
Autores principales: | Brouns, Steffie H., Brüggemann, Renée, Linkens, Aimée E. M. J. H., Magdelijns, Fabienne J., Joosten, Hanneke, Heijnen, Ron, ten Cate‐Hoek, Arina J., Schols, Jos M. G. A., ten Cate, Hugo, Spaetgens, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361386/ https://www.ncbi.nlm.nih.gov/pubmed/32633418 http://dx.doi.org/10.1111/jgs.16664 |
Ejemplares similares
-
A known unknown? Pharmacological prevention of venous thromboembolism in nursing home residents
por: Brüggemann, Renée A. G., et al.
Publicado: (2021) -
Postinterventional antithrombotic management after venous stenting of the iliofemoral tract in acute and chronic thrombosis: A systematic review
por: Notten, Pascale, et al.
Publicado: (2021) -
Management and outcomes of a COVID‐19 outbreak in a nursing home with predominantly Black residents
por: Beiting, Kimberly J., et al.
Publicado: (2021) -
Fisetin for COVID‐19 in skilled nursing facilities: Senolytic trials in the COVID era
por: Verdoorn, Brandon P., et al.
Publicado: (2021) -
Application of the Haddon matrix to COVID‐19 prevention and containment in nursing homes
por: Fritch, William M., et al.
Publicado: (2021)